Zevra Therapeutics Inc. Common Stock is a biotechnology company that develops innovative therapies for various diseases, including cancer, neurodegenerative disorders, and autoimmune conditions. With cutting-edge research and a strong focus on precision medicine, Zevra Therapeutics is advancing the field of personalized healthcare.
Notification